Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer

Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades

(2019) Tao Lu et al.   Cancer Management and Research

Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients

(2019) Yi Zhang et al.   PATHOLOGY RESEARCH AND PRACTICE

MiR-216b suppresses cell proliferation, migration, invasion, and epithelial–mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer

(2019) Lidong Wang et al.   OncoTargets and Therapy

MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS

(2018) Xinquan Wu et al.   Archives of Medical Science

Downregulation of microRNA-216b contributes to glioma cell growth and migration by promoting AEG-1-mediated signaling

(2018) Qi Li et al.   BIOMEDICINE & PHARMACOTHERAPY

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

(2018) Yanfen Yao et al.   OncoTargets and Therapy

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma

(2018) Yan Wang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1

(2017) Tingting Zhang et al.   ONCOLOGY REPORTS

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun

(2017) Gang Huang et al.   Oncotarget

Lung cancer and metastasis: new opportunities and challenges

(2015) Xiangdong Wang et al.   CANCER AND METASTASIS REVIEWS

Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment

(2015) Akhil Srivastava et al.   CURRENT GENE THERAPY

MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway

(2015) F-y Liu et al.   Cell Death & Disease

Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway

(2015) Feng Wang et al.   Oncotarget

Human leukocyte antigen(HLA)-Ggene polymorphism in patients with non-small cell lung cancer

(2015) Aneta Kowal et al.   Thoracic Cancer

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma

(2011) Min Deng et al.   JOURNAL OF CELL SCIENCE

MicroRNA: Biogenesis, Function and Role in Cancer

(2010) Leigh-Ann MacFarlane et al.   CURRENT GENOMICS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL